IL17A and atherosclerosis: In contrast, deletion of IL-23 and IL-22 in hematopoietic cells is shown to promote atherosclerosis progression without affecting IL-17 expression in the aortic plaque of Ldlr−/− mice fed with a 16-week HFD.